Concerning "pharmacovigilance", i.e. the strengthening of the EU system for safety monitoring of medicinal products, ministers warmly welcomed the Commission proposals for a regulation and a directive, and highlighted their contribution to the protection of patients.
Seoses ravimiohutuse järelevalvega, st ELi ravimite ohutuse järelevalve süsteemi tugevdamisega, tervitasid ministrid soojalt komisjoni määruse ja direktiivi ettepanekuid ning rõhutasid nende panust patsientide kaitsesse.